跳至主要内容
临床试验/JPRN-jRCT1080224974
JPRN-jRCT1080224974已完成1 期

Phase 1 clinical trial of Boron Neutron Capture Therapy (BNCT) using CICS-1 and SPM-011 for Malignant melanoma and angiosarcoma

Cancer Intelligence Care Systems, Inc0 个研究点目标入组 10 人开始时间: 2019年12月3日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 85age old(—)
性别
All

入选标准

  • 1.Patients with primary malignant melanoma or angiosarcoma diagnosed histopathologically
  • 2.Patients with superficial skin lesions whose maximum diameter of the target lesion is 15 cm or less
  • 3.Patients with lesions that are 6 cm or less from the skin surface to the deepest part of the tumor
  • 4.Patients with lesions in the head, neck, chest, or extremities
  • 5.Patients who do not have apparent abnormal values in the latest screening test within 28 days of registration

排除标准

  • 1.Patients with obvious disseminated lesions
  • 2.Patients who have undergone previous treatment of radiation therapy exceeding 75 Gy for the target lesion.
  • 3.Patients with active lesions / active multiple cancers in addition to the target lesion
  • 4.Patients with infections that require systemic treatment.
  • 5.Patients with active implantable medical devices
  • 6. Patients with a history of BNCT treatment

研究者

相似试验